Loading quotes...
Forecast
The analysts' average price target is €82.89 (+22.35%). The median is €82.89 (+22.35%).
| Buy |
Â
10 |
| Hold |
Â
3 |
| Sell |
Â
0 |
News Go to news feed
U.S. Physical Therapy expands hospital alliances with NYU Langone to boost visits and reimbursement
U.S. Physical Therapy is pursuing growth through clinic openings, acquisitions and hospital alliances, highlighted by a 10-year NYU Langone partnership that added 60 New York locations and yields flat per-visit payments with higher, more predictable reimbursement. The company opens about 25–30 clinics organically and acquires 30–70 annually using a local-partnership model that preserves clinician ownership and brands. Its injury-prevention unit has grown to roughly $120 million in revenue and more than $20 million in EBITDA, delivering margins about twice those of the physical therapy segment. Management reports about $220 million in debt, expects EBITDA above $100 million for the year, and has capital available for further expansion and share repurchases. » More on finance.yahoo.com
U.S. Physical Therapy relies on partnerships and Briotix to offset Medicare pressure
U.S. Physical Therapy pursues a growth strategy based on a partnership model, hospital alliances (including an exclusive deal with NYU Langone) and expansion of its Briotix division to compensate for lower Medicare reimbursements and competition in the outpatient market. The NYU partnership is expected to bring about 700,000 additional treatments per year long term; Briotix generates roughly $120 million in revenue with substantially higher margins than the physical therapy business. Management views debt of about $220 million and expected EBITDA above $100 million as a manageable framework; it anticipates recoveries in Medicare reimbursement from 2024/2025 and stronger increases from 2028. » More on de.investing.com
Nchacha Etta to become CFO of U.S. Physical Therapy
U.S. Physical Therapy appoints Nchacha Etta effective September 1, 2026, as executive vice president and chief financial officer. Etta previously served as CFO at Omnicell and held financial leadership roles at Essilor of America, Johnson & Johnson Vision and Coca‑Cola; he also sits on the board of directors of KBR. Jason Curtis will remain senior vice president for finance and accounting and will return to that role after serving as interim CFO. U.S. Physical Therapy operates 796 outpatient physical therapy clinics in 45 U.S. states. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 187.56M | 34.65% |
| Gross profit | 36.75M | 4.07% |
| Net profit | 1.41M | 81.21% |
| EBITDA | 24.43M | 7.49% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.03B |
Number of shares | 15.22M |
52-week high/low | €80.73 - €50.24 |
Dividend yield | 2.31% |
Dividends TTM | €1.56 |
Next dividend | €0.39 |
Beta | 1.13 |
P/E ratio | 460.41 |
PEG ratio | -4.97 |
P/B ratio | 2.63 |
P/S ratio | 1.53 |
Company profile
U.S. Physical Therapy, Inc. betreibt über seine Tochtergesellschaften ambulante Physiotherapiekliniken, die prä- und postoperative Behandlungen für orthopädische Erkrankungen, Sportverletzungen, Präventivmedizin, Rehabilitation von verletzten Arbeitnehmern und neurologische Verletzungen anbieten. Das Unternehmen ist in zwei Segmenten tätig: Physikalische Therapie und Prävention von Arbeitsunfällen. Das Unternehmen bietet Dienstleistungen zur Prävention von Arbeitsunfällen an, einschließlich Verletzungsprävention und Rehabilitation vor Ort, Leistungsoptimierung, Tests nach der Einstellung, Bewertungen der funktionellen Leistungsfähigkeit und ergonomische Bewertungen durch Physiotherapeuten und spezialisierte zertifizierte Sporttrainer für Fortune-500-Unternehmen und andere Kunden, zu denen Versicherer und deren Vertragspartner gehören. Zum 31. Dezember 2021 betrieb das Unternehmen 591 Kliniken in 39 Bundesstaaten und verwaltete 35 physiotherapeutische Praxiseinrichtungen. Das Unternehmen wurde 1990 gegründet und hat seinen Sitz in Houston, Texas.
| Name | U.S. Physical Therapy |
| CEO | Christopher J. Reading |
| Headquarters | Houston,
tx USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| IPO | 05/29/1992 |
| Employees | 6,374 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | USPH |
Frankfurt | UPH.F |
DĂĽsseldorf | UPH.DU |
Discover assets
Shareholders of U.S. Physical Therapy also invest in the following assets
